Involvement of cysteine proteases in bFGF-induced angiogenesis in guinea pig and rat cornea

Yoshiyuki Tamada, Chiho Fukiage, Daniel L. Boyle, Mitsuyoshi Azuma, Thomas (Tom) Shearer

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Overexpression and activation of matrix metalloprotease (MMP) have been implicated in angiogenesis. However, the involvement of cysteine proteases, such as calpains (EC 34.22.17), is obscure. Thus, the purpose of this experiment was to study the involvement of cysteine proteases in angiogenesis induced by basic fibroblast growth factor (bFGF) in guinea pig and rat corneas using cysteine protease inhibitors. Sustained-release polymers containing bFGF were implanted into guinea pig and rat corneas to induce angiogenesis. For treatment of corneal angiogenesis, polymers containing cysteine protease inhibitors, leupeptin or SJA6017, were also implanted into corneas. Using the slit lamp, the corneas were observed for nine days after polymer implantation. Soluble proteins and albumin levels were used as markers of corneal injury by angiogenesis, bFGF induced angiogenesis in guinea pig and rat corneas. In guinea pig cornea, wet weight, the amount of soluble protein and albumin was highest at four days after bFGF-containing pellet implantation. In rat cornea, the amount of soluble protein and albumin was highest at six days, and wet weight increased within four days. One hundred nmole of leupeptin showed a tendency to reduce bFGF-induced angiogenesis in guinea pig cornea, and 10 nmole of SJA6017 was effective in reducing bFGF-induced angiogenesis in rat cornea, although SJA6017 showed a stronger effect than leupeptin. Ten nmole of SJA6017 significantly reduced the number of new blood vessels. These data suggested involvement of cysteine proteases in angiogenesis in guinea pig and rat cornea.

Original languageEnglish (US)
Pages (from-to)271-283
Number of pages13
JournalJournal of Ocular Pharmacology and Therapeutics
Volume16
Issue number3
StatePublished - Jun 2000

Fingerprint

Cysteine Proteases
Fibroblast Growth Factor 2
Cornea
Guinea Pigs
Corneal Neovascularization
Cysteine Proteinase Inhibitors
Albumins
Polymers
Weights and Measures
Proteins
Calpain
Metalloproteases
Blood Vessels

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Ophthalmology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Involvement of cysteine proteases in bFGF-induced angiogenesis in guinea pig and rat cornea. / Tamada, Yoshiyuki; Fukiage, Chiho; Boyle, Daniel L.; Azuma, Mitsuyoshi; Shearer, Thomas (Tom).

In: Journal of Ocular Pharmacology and Therapeutics, Vol. 16, No. 3, 06.2000, p. 271-283.

Research output: Contribution to journalArticle

Tamada, Yoshiyuki ; Fukiage, Chiho ; Boyle, Daniel L. ; Azuma, Mitsuyoshi ; Shearer, Thomas (Tom). / Involvement of cysteine proteases in bFGF-induced angiogenesis in guinea pig and rat cornea. In: Journal of Ocular Pharmacology and Therapeutics. 2000 ; Vol. 16, No. 3. pp. 271-283.
@article{759e1c9b959f486b972ba02b0b6f39e2,
title = "Involvement of cysteine proteases in bFGF-induced angiogenesis in guinea pig and rat cornea",
abstract = "Overexpression and activation of matrix metalloprotease (MMP) have been implicated in angiogenesis. However, the involvement of cysteine proteases, such as calpains (EC 34.22.17), is obscure. Thus, the purpose of this experiment was to study the involvement of cysteine proteases in angiogenesis induced by basic fibroblast growth factor (bFGF) in guinea pig and rat corneas using cysteine protease inhibitors. Sustained-release polymers containing bFGF were implanted into guinea pig and rat corneas to induce angiogenesis. For treatment of corneal angiogenesis, polymers containing cysteine protease inhibitors, leupeptin or SJA6017, were also implanted into corneas. Using the slit lamp, the corneas were observed for nine days after polymer implantation. Soluble proteins and albumin levels were used as markers of corneal injury by angiogenesis, bFGF induced angiogenesis in guinea pig and rat corneas. In guinea pig cornea, wet weight, the amount of soluble protein and albumin was highest at four days after bFGF-containing pellet implantation. In rat cornea, the amount of soluble protein and albumin was highest at six days, and wet weight increased within four days. One hundred nmole of leupeptin showed a tendency to reduce bFGF-induced angiogenesis in guinea pig cornea, and 10 nmole of SJA6017 was effective in reducing bFGF-induced angiogenesis in rat cornea, although SJA6017 showed a stronger effect than leupeptin. Ten nmole of SJA6017 significantly reduced the number of new blood vessels. These data suggested involvement of cysteine proteases in angiogenesis in guinea pig and rat cornea.",
author = "Yoshiyuki Tamada and Chiho Fukiage and Boyle, {Daniel L.} and Mitsuyoshi Azuma and Shearer, {Thomas (Tom)}",
year = "2000",
month = "6",
language = "English (US)",
volume = "16",
pages = "271--283",
journal = "Journal of Ocular Pharmacology and Therapeutics",
issn = "1080-7683",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Involvement of cysteine proteases in bFGF-induced angiogenesis in guinea pig and rat cornea

AU - Tamada, Yoshiyuki

AU - Fukiage, Chiho

AU - Boyle, Daniel L.

AU - Azuma, Mitsuyoshi

AU - Shearer, Thomas (Tom)

PY - 2000/6

Y1 - 2000/6

N2 - Overexpression and activation of matrix metalloprotease (MMP) have been implicated in angiogenesis. However, the involvement of cysteine proteases, such as calpains (EC 34.22.17), is obscure. Thus, the purpose of this experiment was to study the involvement of cysteine proteases in angiogenesis induced by basic fibroblast growth factor (bFGF) in guinea pig and rat corneas using cysteine protease inhibitors. Sustained-release polymers containing bFGF were implanted into guinea pig and rat corneas to induce angiogenesis. For treatment of corneal angiogenesis, polymers containing cysteine protease inhibitors, leupeptin or SJA6017, were also implanted into corneas. Using the slit lamp, the corneas were observed for nine days after polymer implantation. Soluble proteins and albumin levels were used as markers of corneal injury by angiogenesis, bFGF induced angiogenesis in guinea pig and rat corneas. In guinea pig cornea, wet weight, the amount of soluble protein and albumin was highest at four days after bFGF-containing pellet implantation. In rat cornea, the amount of soluble protein and albumin was highest at six days, and wet weight increased within four days. One hundred nmole of leupeptin showed a tendency to reduce bFGF-induced angiogenesis in guinea pig cornea, and 10 nmole of SJA6017 was effective in reducing bFGF-induced angiogenesis in rat cornea, although SJA6017 showed a stronger effect than leupeptin. Ten nmole of SJA6017 significantly reduced the number of new blood vessels. These data suggested involvement of cysteine proteases in angiogenesis in guinea pig and rat cornea.

AB - Overexpression and activation of matrix metalloprotease (MMP) have been implicated in angiogenesis. However, the involvement of cysteine proteases, such as calpains (EC 34.22.17), is obscure. Thus, the purpose of this experiment was to study the involvement of cysteine proteases in angiogenesis induced by basic fibroblast growth factor (bFGF) in guinea pig and rat corneas using cysteine protease inhibitors. Sustained-release polymers containing bFGF were implanted into guinea pig and rat corneas to induce angiogenesis. For treatment of corneal angiogenesis, polymers containing cysteine protease inhibitors, leupeptin or SJA6017, were also implanted into corneas. Using the slit lamp, the corneas were observed for nine days after polymer implantation. Soluble proteins and albumin levels were used as markers of corneal injury by angiogenesis, bFGF induced angiogenesis in guinea pig and rat corneas. In guinea pig cornea, wet weight, the amount of soluble protein and albumin was highest at four days after bFGF-containing pellet implantation. In rat cornea, the amount of soluble protein and albumin was highest at six days, and wet weight increased within four days. One hundred nmole of leupeptin showed a tendency to reduce bFGF-induced angiogenesis in guinea pig cornea, and 10 nmole of SJA6017 was effective in reducing bFGF-induced angiogenesis in rat cornea, although SJA6017 showed a stronger effect than leupeptin. Ten nmole of SJA6017 significantly reduced the number of new blood vessels. These data suggested involvement of cysteine proteases in angiogenesis in guinea pig and rat cornea.

UR - http://www.scopus.com/inward/record.url?scp=0034122189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034122189&partnerID=8YFLogxK

M3 - Article

C2 - 10872924

AN - SCOPUS:0034122189

VL - 16

SP - 271

EP - 283

JO - Journal of Ocular Pharmacology and Therapeutics

JF - Journal of Ocular Pharmacology and Therapeutics

SN - 1080-7683

IS - 3

ER -